The therapeutic effects of a medicine are overstated in dose-related adverse drug responses. For instance, if a medication to lower high blood pressure lowers blood pressure too much, the patient may have light headedness or dizziness. If insulin or another antidiabetic treatment lowers the blood sugar level too much, a person with diabetes may experience weakness, sweating, nausea, and palpitations. While mostly avoided, this kind of negative medication response can occur. It might happen if a drug dose is too high (overdose response), if the person is exceptionally sensitive to the medicine, or if another drug delays the first drug's metabolism, increasing its level in the blood (see Drug Interactions). Dose-related responses might be significant or not, however they are relatively common. An adverse drug response (ADR) is a medication's unintended, unpleasant side effect that develops during routine therapeutic usage. Adverse medication responses nearly often occur in medical facilities and can have a negative impact on a patient's quality of life, frequently leading to significant morbidity and mortality. Patients who experience adverse medication responses may become dissatisfied with or feel unkind toward their doctors and turn to other forms of self-care, which might lead to the development of more ADRs.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India